StocksGlaxoSmithKline plc ADRGSK

GSK

GlaxoSmithKline plc ADR

41.02 -0.58 (-1.39%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
40.95
B
41.05

Overview

Prev Close41.02
Day's Range40.76 - 41.28
52 Week Range32.67 - 43.61
Average Volume (3m)4.13M
1-Year Return15.41%
Beta0.6099
Market Cap104.17B
P/E Ratio17.52
Revenue45.59B
EPS2.3742
Dividend (Yield)2.1738 (5.30%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Pharmaceuticals Major
CEO Emma N. Walmsley
Employees 94,066

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2020: GlaxoSmithKline plc ADR's revenues increased by 1.55% and amounted to 43.73B. Net income increased by 21.89% to 8.19B. Net assets increased by 16.96% to 28.44B and EPS increased from 2.36 to 2.93.
GSK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
67.69%
Net Profit Margin
10.14%
Operating Margin
20.92%
Return On Investment
11.79%
12/20
03/21
06/21
09/21
Total Revenue
11.54B
10.23B
11.32B
12.51B
Gross Profit
7.61B
6.86B
7.78B
8.6B
Operating Income
1.92B
2.07B
2.53B
3.01B
Net Income
1.11B
1.74B
2.15B
1.88B